



On April 18-22, 2005 Barcelona hosted
the 2005 International Conference on
Robotics and Automation (ICRA’05),
which was chaired by Alicia Casals, from
the Department of Systems Engineering,
Automation and Industrial Informatics of
the Technical University of Catalonia
(UPC). Throughout the seven-year span
since the meeting had been last held in
Europe (Leuven, Belgium 1998), the con-
tinuous advancement in robotics, au-
tomation and their related areas pro-
duced great changes in the way we use
and apply robots. The motto of the
ICRA’05 conference, Robots get closer
to humans, raised issues in matters relat-
ed to human–robot interaction, in ad-
vances and experiences of robots and
automation at home, at work, for educa-
tion, as well as in other emerging areas.
Operating closer and closer with hu-
mans, robot interaction is an increasing
research topic in robotics.
Sponsor of the ICRAs is the IEEE Ro-
botics & Automation Society (IEEE
stands for the Institute of Electrical and
Electronics Engineers, Inc). The IEEE is a
non-profit, technical professional associ-
ation that gathers more than 377,000 in-
dividual members from 150 countries.
The Robotics & Automation Society is a
thriving worldwide research association
working on the future of robotics. The
ICRA’05 was a most suitable forum for
experts and professionals to discuss on
robotics and automation in technical ar-
eas including computer engineering, bio-
medical technology and telecommunica-
tions, electric power, aerospace, and
consumer electronics.
One hundred years of the
Institut Químic de Sarrià
(IQS Technical College)
On August 15, 1905 the Jesuit Father
Eduardo Vitoria founded the Laboratorio
Químico del Ebro in Roquetes, Tarrago-
na, Spain. The following year the centre
was moved to Barcelona, which was the
core of scientific and industrial activity in
Catalonia, and it was renamed Instituto
Químico de Sarrià (IQS). Its first students
were graduates who took three-year
courses during which they spent five
hours a day in the lab in order to further
their knowledge in the field of chemistry.
Devoting much time to practical work
in the laboratory has been a main feature
of the curriculum at the IQS for more than
fifty years. In 1965 the IQS was approved
as a Private Technical College and in
1973 it became a Coordinated School of
the Spanish Council of Scientific Re-
search (CSIC). In 1980 the Ministry of
Universities and Research authorised the
IQS syllabus for Industrial Engineering
specialising in Chemistry. When Ramon
Llull University –Catalonia’s first private
university– was set up in 1991, IQS be-




The European Federation of Biotechnolo-
gy (EFB) has established its permanent
Central Office (ECO) in Barcelona. The
EFB, founded in 1978, aims at promoting
safe and ethically acceptable biotechnolo-
gy for the better use of Nature’s resources.
It also wishes to expand collaborations be-
tween academic and industrial resear-
chers throughout Europe to increase com-
petencies, strengthen education, promote
innovation and increase the benefits of bio-
technological research to society at large.
EFB holds a biennial European Congress
on Biotechnology that gathers around a
thousand people.
A Committee of the EFB Executive
Board evaluated four bids received and
recommended the proposal received from
Barcelona BioRegion and the Spanish So-
ciety for Biotechnology to locate ECO at
the premises of the Catalan Foundation for
Research and Innovation in Barcelona.
The EFB Executive Board accepted unan-
imously the recommendation, and the
ECO was opened with generous financial
support from the Barcelona Bioregion.
The EFB is open to universities, scientific
institutes, companies, National Bioindustry
Associations (institutional members) and
personal members. While there is a modest
membership fee for institutional members,
personal EFB membership is free of charge.
More than 3000 scientists and students
throughout Europe currently participate in
EFB’s Sections according to their special
topical interests (personal members have to
join one or more EFB Section/s). The EFB
has good contacts with the European Com-
mission’s Research Directorate-General.
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Barcelona led by Rosa Maria Lamuela
carried out a study on the red grape origin
of ancient Egyptian archaeological re-
sidues. Since the Early Dynastic period
(2920–2575 BC) wine jars were placed in
tombs as funerary meals. Egyptian New
Kingdom (1550–1070 BC) wine jars were
labelled with product, year source, and
even the name of vine grower. However,
there was no mention of the kind of wine
they contained. Lamuela and co-workers
have developed a sensitive and highly
specific method for identification of wine
markers that might be present just in trace
amounts. Such a method combines liquid
chromatography with mass spectrometry
in tandem mode (LC/MS/MS) plus alka-
line fusion. LC/MS/MS is a very sensitive
and highly specific analytical method that
allowed detecting tartaric acid at trace
levels. Alkaline fusion was carried out to
identify syringic acid derived from malvidin
as a red wine marker in a deposit residue
from a wine jar found at the tomb of Tu-
tankhamun. Not only did the authors
identify the presence of wine in jar
residues from that tomb, but they also
found out the red grape origin of the wine.
Joan Massagué and
co-workers identify genes
for the spread of breast
cancer to the lungs
In the July 28, 2005 issue of Nature,
Joan Massagué and co-workers at the
Memorial Sloan-Kettering Center in New
York published the results of a new find-
ing on breast cancer. They have identi-
fied a set of genes responsible for
spreading the tumour to the lungs. By
identifying such genes it is also possible
to know how virulent the cancer will be-
come. In 2003, Massagué’s team had
identified, also in breast cancer cells, an-
other set of genes responsible for metas-
tasis to bone. Both sets have only six
genes in common. The latest work
shows that the ability of a tumour to
forms metastases depends on the com-
bined action of multiple genes, and that
different sets of genes lead the spread to
different organs, contrary to the tradi-
tional assumption that there were no
genes that govern metastases to specific
organs. 
James Watson, Doctor
Honoris Causa by the
Autonomous University of
Barcelona
On May 24, 2005 the Autonomous Uni-
versity of Barcelona conferred the acad-
emic title of Doctor Honoris Causa to
James Watson, co-discoverer of the
structure of DNA in 1953 –he was a 24-
year old researcher– and awarded with
1962 Nobel Prize in Physiology or Medi-
cine, which he shared with Francis Crick
and Maurice Wilkins.
In his doctoral address, Watson
defended therapeutic clonation and stat-
ed his opinion that both governments
and churches must be away and out
from genetics, because only the mother
can set the limits to the manipulation of
embrionary genes. Watson reminded
that the role of research is to “cure dis-
eases”; therefore, the fear of non quanti-
fied dangers cannot delay experiments
that might bring benefits to humankind.
Paul Dayton awarded the
First Ramon Margalef Prize
in Ecology and
Environmental Sciences
The USA-born professor and researcher
in ecology Paul Dayton was awarded the
First Ramon Margalef Prize in Ecology
and Environmental Sciences. Dayton
works at the Scripps Institution of
Oceanography, in the University of Cali-
fornia, San Diego. The Autonomous
Government of Catalonia decided to ho-
nour the memory of Ramon Margalef
(1919-2004, see biography and bibliog-
raphy on p. 297 this issue) by establish-
ing an international prize under his na-
me. The Ramon Margalef Prize in Ecolo-
gy and Environmental Sciences, worth
100.000 É, is the most important prize
awarded by this institution, aiming at rec-
ognizing those persons from different
places in the world distinguished in the
field of ecology or the environmental sci-
ences.
Dayton is a pioneer in population and
community ecology among aquatic, ma-
rine and terrestrial researchers. His work
on coastal, estuarine and Antarctic habi-
tats, carried out over his 35-year career at
Scripps, has been recognized worldwide.
He has contributed to solving environ-
mental problems and has stressed the
need to manage marine resources from a
sustainable point of view. In addition to
being an outstanding ecologist, Dayton
has trained many generations of scien-
tists to whom he has conveyed the value
of natural history and field studies, the
importance of historical literature, the
awareness of the vulnerability and fragility
of coastal ecosystems, and the signifi-
cance of working for the benefit of Nature.
Pedro Alonso, from the
University of Barcelona,
selected a solidarity hero
by Time magazine
Time magazine devoted its cover story of
the November 7, 2005 issue to the fight
against diseases that affect developing
countries. The magazine highlighted the
work carried out by 18 “solidarity he-
roes”, as Time called a group made up of
physicians, researchers, and non-gov-
ernmental organizations. Among these
heroes is Pedro Alonso, director of the In-
ternational Health Center of the Hospital
Clínic of the University of Barcelona and
the International Preventive Treatment of
Infants (IPTi, see CONTRIBUTIONS TO SCI-
ENCE [2005] 3:111–112). Alonso leads a
research team that has focused its work
on the development of a vaccine against
malaria, a disease that annually kills
1.5–2.7 million people worldwide Expec-
tations regarding the candidate vaccine
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currently being tested (RTS.S/AS02A)
are quite high. A follow-up of 1442 chil-
dren who were inoculated in 2003 has
shown that the vaccine has retained its
efficiency over a 1.5-year period. The
RTS.S/AS02A vaccine reduced clinical
malaria in 35% of vaccinated individuals,
and the severe malaria in 49%. These re-
sults, published recently in The Lancet
and presented at the Multilateral Initiative
on Malaria’s Pan-African Malaria Confer-
ence, held in Yaounde, Cameroon, in No-
vember 2005, are very promising. The
vaccination project is a joint venture of
the International Health Center in
Barcelona, GlaxoSmithKline (GSK) Bio-
logicals, and the Center for Health Re-
search in Manhiça, Mozambique, and
has received funds from the Bill & Melin-
da Gates Foundation.
News 321
187-324 Contributios 3.2  4/5/07  08:40  Página 321
